Tempus AI Shares Are Trading Higher After the Company Announced It Was Granted Advanced Diagnostic Laboratory Test Status for Its Next-generation Sequencing Assay From the Centers for Medicare & Medicaid Services.
Tempus AI Shares Are Trading Higher After the Company Announced It Was Granted Advanced Diagnostic Laboratory Test Status for Its Next-generation Sequencing Assay From the Centers for Medicare & Medicaid Services.
Tempus人工智能股票上漲了，因爲該公司宣佈從醫療保險和醫療補助服務中心獲得了其下一代測序試驗的先進診斷實驗室檢測狀態。
Tempus AI Shares Are Trading Higher After the Company Announced It Was Granted Advanced Diagnostic Laboratory Test Status for Its Next-generation Sequencing Assay From the Centers for Medicare & Medicaid Services.
Tempus人工智能股票上漲了，因爲該公司宣佈從醫療保險和醫療補助服務中心獲得了其下一代測序試驗的先進診斷實驗室檢測狀態。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。